2021-10-14
A Double Blessing Has Descended upon the House!
Learn More2021-09-14
Breaking the new record of product development speed of emerging technologies, Triastek’s third in-house developed drug T21 submitted the PIND meeting request to the FDA
Learn More2021-07-14
Triastek Closes US$ 50 Million Series B Financing, Co-led by Matrix Partners China and CPE
Learn More2021-02-09
MED™ 3D Printed Pharmaceutical Product Receives IND Clearance From the US FDA
Learn More2020-12-15
TRIASTEK RAISES $15M TO ACCELERATE DEVELOPMENT OF 3D PRINTED DRUGS
Learn MoreBD@triastek.com
苏ICP备17053162号 苏公网安备 32011502011777号
All Rights Reserved
Copyright © 2024 (TRIASTEK)
Contact Us
BD@triastek.comCOPYRIGHT © 2024 TRIASTEK. 苏ICP备17053162号
DIGITAL By VTHINK